Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Treatment of human disease
- Gregor Mendel - 1865
- Archibald Garrod 1908
- Mutation, disease & therapeutic approaches
- DNA structure discovery
- Can DNA be a therapeutic agent?
- Lesch-Nyhan disease
- Metabolic pathway of Lesch-Nyhan disease
- Can we modify cells with foreign DNA? (1)
- Can we modify cells with foreign DNA? (2)
- HPRT(-) cells can't incorporate hypoxanthine
- Transient HPRT expression after transfection
- Viruses as vectors
- Converting normal cells into tumor cells with a virus
- 1972 - human gene therapy paper
- Gene transfer by retrovirus
- Retroviral vector corrects a disease phenotype
- Different vectors for transferring DNA into cells
- Extensive regulation and oversight
- Optimism about human gene therapy (1)
- Optimism about human gene therapy (2)
- A difficult controversial beginning
- Criticism against human gene therapy
- Gene transfer trials by year
- Death from gene therapy trial - 1999 (1)
- Death from gene therapy trial - 1999 (2)
- Severe combined immunodeficiency diseases
- Texas bubble boy
- SCID-X1; Gamma-c deficiency
- Success, but at a cost
- A vector integrated foreign DNA into the lmo2 gene
- Leber's congenital amaurosis
- Why do children with Leber's not see?
- rRPE65 defect in a dog model
- Sub-retinal injection of AAV2.hRPE65v2
- Gene therapy for Leber's amaurosis
- Summary - the reality of gene therapy
Topics Covered
- Background in genetic concepts
- Application by Sir Archibald Garrod to human disease
- Discovery of the structure of DNA and new opportunities to understand and manipulate genes
- Proof of principle of gene transfer into human cells using the Lesch Nyhan disease model
- Rapid expansion of clinical gene therapy trials, high level of optimism and expectation
- Major setback in human OTC gene therapy study
- Patient death
- Scientific and clinical success with another disease model
- Severe combined immunodeficiency (SCID)
- Setback in SCID
- Leukemia in some treated patients
- Additional clinical successes, especially in Leber's congenital blindness
Links
Series:
Categories:
Talk Citation
Friedmann, T. (2010, October 18). The development and evolution of human gene therapy [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/EMRY7540.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Theodore Friedmann has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.